Dengue Moment
For a country that has lived with dengue as a seasonal inevitability, the emergence of DengiAll, India’s indigenous single-shot dengue vaccine now in advanced trials in Delhi, is more than a scientific milestone.
For a country that has lived with dengue as a seasonal inevitability, the emergence of DengiAll, India’s indigenous single-shot dengue vaccine now in advanced trials in Delhi, is more than a scientific milestone.
The World Health Organization (WHO) has donated 2,160 doses of Ebola trial vaccine to Uganda to evaluate the efficacy of the vaccine in combating the virus which in the recent outbreak has killed a health worker in Kampala, the country's capital.
Indonesia is developing a new Tuberculosis (TB) vaccine to strengthen the fight against TB, which has claimed an average of 150,000 lives annually.
The landmark trial will evaluate the efficacy of India’s indigenous tetravalent dengue vaccine, DengiAll, developed by Panacea Biotec.
Specifically, the team compared the immune responses in people who were protected against CMV infection after receiving the older vaccine.
Nadda said the Opposition underestimated the making of vaccines but Prime Minister Modi trusted the scientists that they would make the same within a stipulated time.
clinically tried and tested, regulated and already administered vaccines to over 100 crore people in such a short time, the country has set an extraordinary example in global fight against Covid-19.
The recovery of19,582 patients in the last 24 hours has increased the cumulative tally of recovered patients (since the beginning of the pandemic) to 3,34,39,331.
Regional networking and data-sharing is a must to keep all stakeholders updated about the status of various malaria control programmes across the worst-affected countries in Africa and Asia.
The first Beyond Visual Line of Sight (BVLOS) drone trial run under the project was kick-started in the Vikarabad district of Telangana on September 11.
